VEGFA and renal cell carcinoma: Subsequent investigations have shown that reducing the expression of ETK in renal cell carcinoma hinders the development and spread of cancer cells, and triggers programmed cell death, by reducing the levels of phosphorylated STAT3 (p-STAT3) and vascular endothelial growth factor (VEGF) [54].